Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
119125995 | 11912599 | 5 | F | 2015 | 20160914 | 20160113 | 20160923 | EXP | CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-093211 | BRISTOL MYERS SQUIBB | 61.00 | YR | F | Y | 0.00000 | 20160923 | CN | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
119125995 | 11912599 | 1 | PS | ORENCIA | ABATACEPT | 1 | Unknown | UNK | U | 125118 | |||||||||
119125995 | 11912599 | 2 | SS | ENBREL | ETANERCEPT | 1 | Unknown | U | 0 | ||||||||||
119125995 | 11912599 | 3 | SS | HUMIRA | ADALIMUMAB | 1 | Unknown | U | 0 | ||||||||||
119125995 | 11912599 | 4 | SS | ACTEMRA | TOCILIZUMAB | 1 | Unknown | U | 0 | ||||||||||
119125995 | 11912599 | 5 | C | XELJANZ | TOFACITINIB CITRATE | 1 | Oral | 50 MG, BID | 600 | MG | U | 0 | 50 | MG | TABLET | BID | |||
119125995 | 11912599 | 6 | C | HYDROXYCHLOROQUINE | HYDROXYCHLOROQUINE | 1 | Unknown | 400 MG, UNK | 0 | 400 | MG | ||||||||
119125995 | 11912599 | 7 | C | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | Unknown | UNK | 0 | ||||||||||
119125995 | 11912599 | 8 | C | NAPROXEN. | NAPROXEN | 1 | Unknown | UNK | 0 | ||||||||||
119125995 | 11912599 | 9 | C | PREDNISONE. | PREDNISONE | 1 | Unknown | UNK | 0 | ||||||||||
119125995 | 11912599 | 10 | C | METHOTREXATE. | METHOTREXATE | 1 | Unknown | UNK | U | 0 | |||||||||
119125995 | 11912599 | 11 | C | FOLIC ACID. | FOLIC ACID | 1 | Unknown | U | 0 | ||||||||||
119125995 | 11912599 | 12 | C | PLAQUENIL /00072602/ | HYDROXYCHLOROQUINE DIPHOSPHATE | 1 | Unknown | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
119125995 | 11912599 | 1 | Rheumatoid arthritis |
119125995 | 11912599 | 2 | Rheumatoid arthritis |
119125995 | 11912599 | 3 | Rheumatoid arthritis |
119125995 | 11912599 | 4 | Product used for unknown indication |
119125995 | 11912599 | 5 | Rheumatoid arthritis |
119125995 | 11912599 | 6 | Rheumatoid arthritis |
119125995 | 11912599 | 7 | Rheumatoid arthritis |
119125995 | 11912599 | 8 | Rheumatoid arthritis |
119125995 | 11912599 | 9 | Rheumatoid arthritis |
119125995 | 11912599 | 10 | Product used for unknown indication |
119125995 | 11912599 | 11 | Product used for unknown indication |
119125995 | 11912599 | 12 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
119125995 | 11912599 | HO |
119125995 | 11912599 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
119125995 | 11912599 | Arthropathy | |
119125995 | 11912599 | C-reactive protein abnormal | |
119125995 | 11912599 | Drug ineffective | |
119125995 | 11912599 | Fall | |
119125995 | 11912599 | Fatigue | |
119125995 | 11912599 | Femur fracture | |
119125995 | 11912599 | Impaired healing | |
119125995 | 11912599 | Multiple fractures | |
119125995 | 11912599 | Osteoporosis | |
119125995 | 11912599 | Pain | |
119125995 | 11912599 | Rash | |
119125995 | 11912599 | Red blood cell sedimentation rate abnormal | |
119125995 | 11912599 | Surgery | |
119125995 | 11912599 | Synovitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
119125995 | 11912599 | 5 | 20151110 | 20151115 | 0 | |
119125995 | 11912599 | 6 | 201201 | 0 | ||
119125995 | 11912599 | 7 | 201401 | 0 | ||
119125995 | 11912599 | 10 | 2012 | 2014 | 0 |